Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Katayose

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Biochemical and Biophysical Research Communications|March 18, 2023
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancerAkihiro Yasumoto, Haruna Fujimori, Mai Mochizuki, et al.
British Journal of Cancer|July 10, 2019
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)Eiji Oki, Yasunori Emi, Takeharu Yamanaka, et al.
Clinical Proteomics|August 16, 2012
Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissueTatsuyuki Takadate, Tohru Onogawa, Kiyonaga Fujii, et al.
Oncology Reports|July 12, 2011
In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibodyYasuhiro Watanabe, Ryutaro Asano, Kyoko Arai, et al.
Hepato-Gastroenterology|January 12, 2012
Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study)Yu Katayose, Toshiki Rikiyama, Fuyuhiko Motoi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP]Emiko Kono, Naoki Tanaka, Katsuyosi Kudo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery]Hajime Taniguchi, Masamichi Mizuma, Fuyuhiko Motoi, et al.
Journal of Gastroenterology|July 15, 2023
Evidence-based clinical practice guidelines for cholelithiasis 2021Naotaka Fujita, Ichiro Yasuda, Itaru Endo, et al.
Biochemical and Biophysical Research Communications|January 7, 2021
Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related proteinSatoshi Saijoh, Mao Nakamura-Shima, Rie Shibuya-Takahashi, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Biochemical and Biophysical Research Communications|March 18, 2023
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancerAkihiro Yasumoto, Haruna Fujimori, Mai Mochizuki, et al.
British Journal of Cancer|July 10, 2019
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)Eiji Oki, Yasunori Emi, Takeharu Yamanaka, et al.
Clinical Proteomics|August 16, 2012
Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissueTatsuyuki Takadate, Tohru Onogawa, Kiyonaga Fujii, et al.
Oncology Reports|July 12, 2011
In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibodyYasuhiro Watanabe, Ryutaro Asano, Kyoko Arai, et al.
Hepato-Gastroenterology|January 12, 2012
Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study)Yu Katayose, Toshiki Rikiyama, Fuyuhiko Motoi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP]Emiko Kono, Naoki Tanaka, Katsuyosi Kudo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery]Hajime Taniguchi, Masamichi Mizuma, Fuyuhiko Motoi, et al.
Journal of Gastroenterology|July 15, 2023
Evidence-based clinical practice guidelines for cholelithiasis 2021Naotaka Fujita, Ichiro Yasuda, Itaru Endo, et al.
Biochemical and Biophysical Research Communications|January 7, 2021
Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related proteinSatoshi Saijoh, Mao Nakamura-Shima, Rie Shibuya-Takahashi, et al.
Pageof 14